CMIUX | VEURX | CMIUX / VEURX | |
Total Expense Ratio | 0.10 | 0.24 | 42% |
Annual Report Gross Expense Ratio | 0.30 | 0.24 | 125% |
Fund Existence | 6 years | 35 years | - |
Gain YTD | 17.857 | 19.792 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.15B | 29.9B | 27% |
Annual Yield % from dividends | 2.61 | 2.89 | 91% |
Returns for 1 year | 10.98 | 10.35 | 106% |
Returns for 3 years | 45.20 | 30.85 | 146% |
Returns for 5 years | 109.41 | 65.56 | 167% |
Returns for 10 years | N/A | 39.13 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRLAX | 20.03 | 0.09 | +0.45% |
T. Rowe Price Latin America | |||
MIOFX | 27.58 | -0.03 | -0.11% |
Marsico International Opportunities | |||
ETIHX | 31.10 | -0.05 | -0.16% |
Eventide Healthcare & Life Sciences I | |||
FMMMX | 42.71 | -0.35 | -0.81% |
American Funds AMCAP 529-F-2 | |||
CTHRX | 92.02 | -0.94 | -1.01% |
Columbia Global Technology Growth Inst2 |